2ⁿᵈ Edition of the Cancer R&D World Conference 2026

Speakers - CRDWC 2026

Chun Huang, Cancer R&D World Conference, Miami, Florida, USA

Chun Huang

Chun Huang

  • Designation: Johnson & Johnson
  • Country: USA

Biography

Chun Huang, PhD, is a Postdoctoral Researcher in Preclinical Sciences & Translational Safety department at Johnson & Johnson Innovative Medicine, La Jolla, CA. His work focuses on developing human-relevant new approach methodologies (NAMs), including in vitro models to assess immunotoxicity and neurotoxicity risks associated with emerging immunotherapies. He earned his PhD in Immunology from the University of Southern California, where he developed CRISPR-based platforms to engineer B cells for therapeutic antibody expression, mimicking natural antibody production pathways. His research interests center on advancing gene therapy and immunology-driven strategies to enable the development of safer and more effective novel therapeutics.